The Patent Finder

Terms ending in 2030

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,318,760Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,357,7092,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,415,346Inhibitors of Janus Kinases
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,359,339Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,591,878Therapeutic Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,426,598N-Heterocyclic M1 Receptor Positive Allosteric Modulators
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,278,965Bridged and Fused Antidiabetic Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,691,205Mono- and Di-Peg IL-10 Production; and Uses
In force
 · High confidence
Merck Sharp & Dohme Corp.In forceHigh confidence
US 7,973,040Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,507,4773- and 6-Quinolines with N-Attached Heterocyclic CGRP Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
140 more term ends in 2030 · Pro
10 of 150 patents shown. Soonest term end first, then patent number.
Pro members see all 150.
Upgrade to Pro
138 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited